Found: 5
Select item for more details and to access through your institution.
BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
- Published in:
- Diabetologia, 2018, v. 61, n. 11, p. 2422, doi. 10.1007/s00125-018-4696-x
- By:
- Publication type:
- Article
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 5, p. N.PAG, doi. 10.15252/emmm.201910666
- By:
- Publication type:
- Article
Targeting key angiogenic pathways with a bispecific Cross MAb optimized for neovascular eye diseases.
- Published in:
- EMBO Molecular Medicine, 2017, v. 9, n. 7, p. 985, doi. 10.15252/emmm.201707895
- By:
- Publication type:
- Article
Targeting key angiogenic pathways with a bispecific Cross MAb optimized for neovascular eye diseases.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 11, p. 1265, doi. 10.15252/emmm.201505889
- By:
- Publication type:
- Article
Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0065518
- By:
- Publication type:
- Article